Associated Papers
HAMMER: Hairpin-based APOBEC3A-mediated mRNA editing reporter.
Chen Y et al.
Biorxiv : the Preprint Server for Biology, 2026
Guardian ubiquitin E3 ligases target cancer-associated APOBEC3 deaminases for degradation to promote human genome integrity.
Schwartz I et al.
Nature Communications, 2026
Hypomorphic mutation in the large subunit of replication protein A affects mutagenesis by human APOBEC cytidine deaminases in yeast.
Dennen MS et al.
Biorxiv : the Preprint Server for Biology, 2024
Mutational impact of APOBEC3A and APOBEC3B in a human cell line and comparisons to breast cancer.
Carpenter MA et al.
Plos Genetics, 2023
Cellular APOBEC3A deaminase drives mutations in the SARS-CoV-2 genome.
Nakata Y et al.
Nucleic Acids Research, 2023
Activation induced cytidine deaminase: An old friend with new faces.
Çakan E et al.
Frontiers in Immunology, 2022
Divergence in Dimerization and Activity of Primate APOBEC3C.
Gaba A et al.
Journal of Molecular Biology, 2021
Dysregulated APOBEC3G causes DNA damage and promotes genomic instability in multiple myeloma.
Talluri S et al.
Blood Cancer Journal, 2021
APOBEC3A catalyzes mutation and drives carcinogenesis in vivo.
Law EK et al.
The Journal of Experimental Medicine, 2020
The interesting relationship between APOBEC3 deoxycytidine deaminases and cancer: a long road ahead.
Granadillo Rodríguez M et al.
Open Biology, 2020
Optimized high-fidelity 3DPCR to assess potential mitochondrial targeting by activation-induced cytidine deaminase.
Wu H et al.
Febs Open Bio, 2020
The emerging landscape of germline variants in urothelial carcinoma: Implications for genetic testing.
Vlachostergios PJ et al.
Cancer Treatment and Research Communications, 2020
Genome-wide mapping of regions preferentially targeted by the human DNA-cytosine deaminase APOBEC3A using uracil-DNA pulldown and sequencing.
Sakhtemani R et al.
The Journal of Biological Chemistry, 2019
APOBEC3A Loop 1 Is a Determinant for Single-Stranded DNA Binding and Deamination.
Ziegler SJ et al.
Biochemistry, 2019
APOBEC3A is an oral cancer prognostic biomarker in Taiwanese carriers of an APOBEC deletion polymorphism.
Chen TW et al.
Nature Communications, 2017
A Single Nucleotide Polymorphism in Human APOBEC3C Enhances Restriction of Lentiviruses.
Wittkopp CJ et al.
Plos Pathogens, 2016
The ssDNA Mutator APOBEC3A Is Regulated by Cooperative Dimerization.
Bohn MF et al.
Structure (london, England : 1993), 2015
Structural determinants of human APOBEC3A enzymatic and nucleic acid binding properties.
Mitra M et al.
Nucleic Acids Research, 2014
When defense turns into attack: Antiviral cytidine deaminases linked to somatic mutagenesis in HPV-associated cancer.
Henderson S et al.
Molecular & Cellular Oncology, 2014
Deaminase-independent inhibition of parvoviruses by the APOBEC3A cytidine deaminase.
Narvaiza I et al.
Plos Pathogens, 2009